The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma

Leukemia, Published online: 07 March 2024; doi:10.1038/s41375-024-02207-9The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma

https://www.nature.com/articles/s41375-024-02207-9

Source: Leukemia - March 7, 2024 Category: Hematology Authors: Hildo C. Lantermans Fangxue Ma Annemieke Kuil Sanne van Kesteren Sevtap Yasinoglu Guang Yang Sara J. Buhrlage Jinhua Wang Nathanael S. Gray Marie Jos é Kersten Steven P. Treon Steven T. Pals Marcel Spaargaren Source Type: research

More News: Hematology | Leukemia | Lymphoma